Beta
128912

EVALUATION OF THE ANTI-ISCHEMIC EFFECT OF THE PPARy AGONIST, (ROSIGLITAZONE) IN PERMANENT FOCAL CEREBRAL ISCHEMIA IN DIABETIC RATS.

Article

Last updated: 23 Jan 2023